Clinical Trial Update: Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating esomeprazole to prevent upper gastrointestinal symptoms in patients continuously using NSAIDs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Phase 3 | Status: COMPLETED